Suchergebnisse - "*Neoplasms"

PubPharm (264)

1

Next-Generation HER2-Targeted Antibody-Drug Conjugates in Breast Cancer

enthalten in: Cancers | 2024

von Zimmerman, B. | Esteva, F.

2

Understanding Cancer's Defense against Topoisomerase-Active Drugs : A Comprehensive Review

enthalten in: Cancers | 2024

von Sharma, N. | Bahot, A. | Sekar, G. | +6

3

Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review

in: Cancers | 2024

von Nilesh Kumar Sharma | Anjali Bahot | Gopinath Sekar | +6

4

DDX3X and Stress Granules: Emerging Players in Cancer and Drug Resistance

in: Cancers | 2024

von Han Zhang | Paula M. Mañán-Mejías | Hannah N. Miles | +3

5

Suppression of Cancer Cell Stemness and Drug Resistance via MYC Destabilization by Deubiquitinase USP45 Inhibition with a Natural Small Molecule

in: Cancers | 2023

von Xiao Tu | Chuncheng Li | Wen Sun | +5

6

A Network of MicroRNAs and mRNAs Involved in Melanosome Maturation and Trafficking Defines the Lower Response of Pigmentable Melanoma Cells to Targeted Therapy

in: Cancers | 2023

von Marianna Vitiello | Alberto Mercatanti | Maurizio Salvatore Podda | +9

7

Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus

in: Cancers | 2023

von Tong Yu | Archana Chandrabhan Jadhav | Jiabao Xu | +3

8

Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer

in: Cancers | 2023

von Lingyu Han | Weixing Dai | Wenqin Luo | +7

9

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer

in: Cancers | 2023

von Briana Kinnel | Santosh Kumar Singh | Gabriela Oprea-Ilies | +1

10

Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer

in: Cancers | 2023

von Aadya Nagpal | Kristen Needham | Darius J. R. Lane | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]